CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 160044-160481 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1002","span":{"begin":0,"end":437},"obj":"Sentence"},{"id":"T64246","span":{"begin":0,"end":437},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A phase 1 study has recently been completed, although data analysis is ongoing, and other studies are in the planning stages currently. (Mikhail Matrosovich, Philipps University, Marburg, Germany) Influenza virus can develop resistance to neuraminidase inhibitors via changes in the neuraminidase (NA), which results in decreased drug binding, or in the hemagglutinin (HA), which results in lowered HA affinity for its cellular receptor."}

{"project":"Epistemic_Statements","denotations":[{"id":"T370","span":{"begin":0,"end":135},"obj":"Epistemic_statement"},{"id":"T371","span":{"begin":136,"end":437},"obj":"Epistemic_statement"}],"text":"A phase 1 study has recently been completed, although data analysis is ongoing, and other studies are in the planning stages currently. (Mikhail Matrosovich, Philipps University, Marburg, Germany) Influenza virus can develop resistance to neuraminidase inhibitors via changes in the neuraminidase (NA), which results in decreased drug binding, or in the hemagglutinin (HA), which results in lowered HA affinity for its cellular receptor."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T70","span":{"begin":0,"end":437},"obj":"Sentence"}],"text":"A phase 1 study has recently been completed, although data analysis is ongoing, and other studies are in the planning stages currently. (Mikhail Matrosovich, Philipps University, Marburg, Germany) Influenza virus can develop resistance to neuraminidase inhibitors via changes in the neuraminidase (NA), which results in decreased drug binding, or in the hemagglutinin (HA), which results in lowered HA affinity for its cellular receptor."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T851","span":{"begin":197,"end":206},"obj":"Disease"}],"attributes":[{"id":"A851","pred":"mondo_id","subj":"T851","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"A phase 1 study has recently been completed, although data analysis is ongoing, and other studies are in the planning stages currently. (Mikhail Matrosovich, Philipps University, Marburg, Germany) Influenza virus can develop resistance to neuraminidase inhibitors via changes in the neuraminidase (NA), which results in decreased drug binding, or in the hemagglutinin (HA), which results in lowered HA affinity for its cellular receptor."}